據報日本擬修訂法例完善扶持半導體企業設廠 臺積電將成首家補貼對象
《日經新聞》報道,日本政府將完善扶持尖端半導體生產企業的法律制度,補貼在日本國內設廠的企業,修訂法案將在12月舉行的臨時國會上提交。
據悉,目前以5G開發企業爲對象的相關法律,將考慮追加半導體作爲新的重要領域。至於提供補貼的前提是需要制定認定在日本建設的是尖端半導體工廠的規則,並以工廠投產後的穩定生產、投資及繼續開展技術研發等爲條件,並要求在供求緊張時增產,遵守防止技術外流的相關法律等。
市場估計,臺積電(TSM.US)在熊本縣新建的工廠將成爲首家認定對象,該工廠總規模達1萬億日圓,消息指日本政府最高補貼一半。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.